Multivariate Metal-Organic Frameworks based pH-responsive dual-drug delivery system for chemotherapy and chemodynamic therapy

11 July 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Combination therapy has emerged as a promising strategy due to its synergistic therapeutic pathways that enhance anticancer efficacy and limits the emergence of drug resistance. In this work, MIL-88B type multivariate (MTV-1) nanocarriers based on mixed linker (1, 4-benzenedicarboxylic acid and biphenyl-4,4'-dicarboxylic acid ) and metals (iron and cobalt) were synthesized. Presence of the distinct linkers modified the pore makeup of MTV-1 and facilitated the co-encapsulation of two anticancer drugs of varying molecular sizes; 5-Fluorouracil (5-FU) and Curcumin (CUR). The drug loading measurements on MTV-1@5-FU+CUR represented a loading capacity of 15.9wt% for 5-FU and 9.3wt% for CUR, respectively. They further exhibited a pH-responsive drug release pattern with higher concentrations of 5-FU and CUR released at pH 5.5 (simulating cancer microenvironment) compared to pH 7.4 (physiological environment). Moreover, we also demonstrated that MTV-1 MOFs, due to the presence of mixed valence metal ions, could perform peroxidase-like activity and catalyzes H2O2 decomposition to produce •OH radicals for chemodynamic therapy. Cell cytotoxicity assays exhibited significant inhibitory effects of MTV-1@5-Fu+CUR against HepG2 cells with an IC50 of 78.7 g/mL. Together with dual-drug loading, pH-responsive release, and chemodynamic therapy, MTV-1 show excellent potential for multifunctional anticancer treatment.


metal organic frameworks
drug delivery
multivariate MOFs

Supplementary materials

Multivariate MOFs for drug delivery
Mixed-ligand and mixed-metal MOFs show enhanced performance in targeted delivery of two cancer drugs.


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.